May 19, 2020 / 07:05PM GMT
Brian Corey Abrahams - RBC Capital Markets, Research Division - Senior Biotechnology Analyst
Good afternoon, everyone. I'm Brian Abrahams, one of the Senior Biotech Analysts here at RBC Capital Markets. It's my pleasure to introduce our next company, Incyte. Representing Incyte will be their Chairman, President and CEO; Hervé Hoppenot; as well as their Executive Vice President and CFO, Christiana Stamoulis. Hervé and Christiana, thanks so much for joining us today.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Thank you. Good afternoon.
Questions and Answers:
Brian Corey Abrahams - RBC Capital Markets, Research Division - Senior Biotechnology AnalystGreat. So why don't we hop right in? Let's start with Jakafi. It seems like there's been relatively limited impact to the commercial business from the pandemic. And I was wondering if you could maybe talk a little bit about how the dynamics between the MF and PV markets, in particular, have evolved since the pandemic began
Trustpilot
